BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations

  November 11, 2024

   · 

  5 min read
• Press Releases

  Codexis Announces New Employment Inducement Grants - November 8, 2024

  November 11, 2024

   · 

  1 min read
• Press Releases

  PacBio to Present at Upcoming Investor Conferences

  November 11, 2024

   · 

  1 min read
• Press Releases

  Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting

  November 11, 2024

   · 

  8 min read
• Press Releases

  electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) - November 8, 2024

  November 11, 2024

   · 

  1 min read
• Press Releases

  Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 8, 2024

  November 11, 2024

   · 

  2 min read
• Press Releases

  Aptose Reports Results for the Third Quarter 2024

  November 11, 2024

   · 

  13 min read
• Press Releases

  AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE

  November 11, 2024

   · 

  1 min read
• Press Releases

  Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

  November 11, 2024

   · 

  18 min read
• Press Releases

  Gilead Sciences to Present at Upcoming Investor Engagements

  November 11, 2024

   · 

  1 min read